State Street’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.4M Buy
6,694,976
+1,804,451
+37% +$10.4M ﹤0.01% 1934
2025
Q4
$26.3M Buy
4,890,525
+1,784,012
+57% +$8.24M ﹤0.01% 2107
2025
Q3
$10.9M Buy
3,106,513
+1,135,145
+58% +$3.59M ﹤0.01% 2594
2025
Q2
$5.13M Buy
1,971,368
+21,691
+1% +$44.7K ﹤0.01% 2929
2025
Q1
$3.7M Buy
1,949,677
+46,669
+2% +$124K ﹤0.01% 2995
2024
Q4
$2.76M Buy
1,903,008
+39,031
+2% +$64.8K ﹤0.01% 3210
2024
Q3
$3.43M Buy
1,863,977
+3,808
+0.2% +$4.75K ﹤0.01% 3124
2024
Q2
$1.86M Buy
1,860,169
+33,992
+2% +$49.6K ﹤0.01% 3342
2024
Q1
$3.62M Buy
1,826,177
+99,873
+6% +$173K ﹤0.01% 3057
2023
Q4
$2.69M Sell
1,726,304
-29,809
-2% -$51.6K ﹤0.01% 3217
2023
Q3
$3.46M Buy
1,756,113
+9,599
+0.5% +$23.7K ﹤0.01% 3096
2023
Q2
$5.55M Buy
1,746,514
+1,344,201
+334% +$4.22M ﹤0.01% 2945
2023
Q1
$1.32M Buy
402,313
+132,200
+49% +$519K ﹤0.01% 3453
2022
Q4
$1.36M Buy
+270,113
New +$1.08M ﹤0.01% 3488

Other funds holding CMPX